Clinical Trials Browser

Phase 1/2 × Has announcements × Tumor-Agnostic × Clear all

NCT02637687 2025-06-22

SCOUT

Phase 1/2 Active not recruiting

154 enrolled 2 FDA

Neoplasms

NCT02501096 2023-07-20

A Trial of Lenvatinib (E7080) Plus Pembrolizumab in Participants With Selected Solid Tumors

Phase 1/2 Completed

357 enrolled 28 charts 1 FDA

Neoplasms